HPR167 A Comparison of ICER Health-Benefit Price Benchmarks in the United States to Drug Prices in the United Kingdom and France

Abstract

Authors

S Gohil M Chenoweth D Severi Bruni

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×